These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8414387)

  • 1. 1% Cyclopentolate hydrochloride: another look at the time course of cycloplegia using an objective measure of the accommodative response.
    Manny RE; Fern KD; Zervas HJ; Cline GE; Scott SK; White JM; Pass AF
    Optom Vis Sci; 1993 Aug; 70(8):651-65. PubMed ID: 8414387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effects on accommodative and pupillary responses by topical application of cyclopentolate hydrochloride].
    Ohmi G; Kinoshita H; Kinoshita S
    Nippon Ganka Gakkai Zasshi; 1991 Nov; 95(11):1099-104. PubMed ID: 1759650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of topically applied cyclopentolate HCl and tropicamide.
    Lovasik JV
    Am J Optom Physiol Opt; 1986 Oct; 63(10):787-803. PubMed ID: 3777109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prior topical anesthesia reduces time to full cycloplegia in Chinese.
    Siu AW; Sum AC; Lee DT; Tam KW; Chan SW
    Jpn J Ophthalmol; 1999; 43(6):466-71. PubMed ID: 10672874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of iris reactivity to light to determine the peak cycloplegia in hyperopic children.
    Longmuir S; Pfeifer W; Coussens T; Olson RJ
    Insight; 2012; 37(1):12-4, 30. PubMed ID: 22439352
    [No Abstract]   [Full Text] [Related]  

  • 6. Cycloplegia in African-American children.
    Kleinstein RN; Mutti DO; Manny RE; Shin JA; Zadnik K
    Optom Vis Sci; 1999 Feb; 76(2):102-7. PubMed ID: 10082056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Onset and duration of cycloplegic action of 1% cyclopentolate - 1% tropicamide combination.
    Kyei S; Nketsiah AA; Asiedu K; Awuah A; Owusu-Ansah A
    Afr Health Sci; 2017 Sep; 17(3):923-932. PubMed ID: 29085421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of drop instillation and spray application of 1% cyclopentolate hydrochloride.
    Ismail EE; Rouse MW; De Land PN
    Optom Vis Sci; 1994 Apr; 71(4):235-41. PubMed ID: 8047334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical efficacy of paremyd with and without dapiprazole in subjects with light and dark brown irides.
    Anicho UM; Cooper J; Feldman J; Jaanus SD; Dignam K
    Optom Vis Sci; 1999 Feb; 76(2):94-101. PubMed ID: 10082055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 0.1% cyclopentolate or 10% phenylephrine on pupil diameter and accommodation.
    Mordi J; Tucker J; Charman WN
    Ophthalmic Physiol Opt; 1986; 6(2):221-7. PubMed ID: 3748569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of 0.5% cyclopentolate plus 0.5% tropicamide and 1% cyclopentolate alone for mydriasis of dark irides.
    Nishizawa AR; Orton RB; Cadera W
    Can J Ophthalmol; 1988 Dec; 23(7):299-300. PubMed ID: 3228775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors Affecting Pupil Reactivity After Cycloplegia in Asian Children.
    Lim J; Chia A; Saffari SE; Handa S
    Asia Pac J Ophthalmol (Phila); 2019; 8(4):304-307. PubMed ID: 31385819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time course of cycloplegia induced by a new phenylephrine-tropicamide combination drug.
    Lovasik JV; Kergoat H
    Optom Vis Sci; 1990 May; 67(5):352-8. PubMed ID: 2367089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Clinical Randomized Trial Comparing the Cycloplegic Effect of Cyclopentolate Drops Applied to Closed Eyelids Versus Open Eyelids.
    Zurevinsky J; Sawchuk K; Lim HJ; Lee CH; Rubab S
    Am Orthopt J; 2016 Jan; 66(1):114-121. PubMed ID: 27799585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dilation efficacy: is 1% cyclopentolate enough?
    Hug T; Olitsky S
    Optometry; 2007 Mar; 78(3):119-21. PubMed ID: 17321460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of cyclopentolate versus tropicamide cycloplegia in children.
    Egashira SM; Kish LL; Twelker JD; Mutti DO; Zadnik K; Adams AJ
    Optom Vis Sci; 1993 Dec; 70(12):1019-26. PubMed ID: 8115124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of cycloplegic agents: results of a randomized controlled trial in nigerian children.
    Ebri A; Kuper H; Wedner S
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1025-31. PubMed ID: 17325142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cycloplegia and iris pigmentation on postoperative intraocular inflammation.
    Onodera T; Gimbel HV; DeBroff BM
    Ophthalmic Surg; 1993 Nov; 24(11):746-52. PubMed ID: 8290213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of drugs in ointment for mydriasis and cycloplegia.
    Cable MK; Hendrickson RO; Hanna C
    Arch Ophthalmol; 1978 Jan; 96(1):84-6. PubMed ID: 623548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of cycloplegia on measurement of the ocular components.
    Mutti DO; Zadnik K; Egashira S; Kish L; Twelker JD; Adams AJ
    Invest Ophthalmol Vis Sci; 1994 Feb; 35(2):515-27. PubMed ID: 8113002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.